AbbVie, Pfizer Among Drugmakers Tapped to Repay Medicare (1)

High-priced medications from drugmakers like AbbVie and Endo are among those the Biden administration announced will have to pay Medicare back after their prices rose faster than inflation, with an agency official stating that pharmaceutical giants should expect invoices by 2025.

AbbVie’s Humira, Leadiant Biosciences’ Abelcet, Pfizer’s Fragmin, and Kite Pharma’s Tecartus are on the list of the 27 Part B drugs for whom their manufacturers will be required to pay rebates to the Medicare program. Under 2022’s Inflation Reduction Act, drugs whose prices skyrocketed faster than inflation become eligible to pay Medicare rebates. Part B drugs are treatments administered ...